On Tuesday, March 28, 2023, CDER’s Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: Cannabis and Cannabis Derived Products – For Healthcare Practitioners.
This webinar will provide a general understanding of the Cannabis sativa L. plant and how products are generally produced utilizing cannabis raw materials. The presentation will explain why manufacturing controls surrounding cannabis and cannabis-derived products are an integral part of protecting public health and will provide attendees with greater knowledge of the many products available on the marketplace.
